Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.909
-0.051 (-5.33%)
Jan 2, 2025, 9:35 AM EST - Market open
Rallybio Market Cap
Rallybio has a market cap or net worth of $37.70 million as of January 2, 2025. Its market cap has decreased by -67.18% in one year.
Market Cap
37.70M
Enterprise Value
-35.08M
1-Year Change
-67.18%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $37.70M, a decrease of -90.70%. That is a compound annual growth rate of -50.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.13B |
| UnitedHealth Group | 465.54B |
| Novo Nordisk | 384.34B |
| Johnson & Johnson | 348.19B |
| AbbVie | 314.02B |
| Merck & Co. | 251.65B |
| AstraZeneca | 203.17B |
| Thermo Fisher Scientific | 198.99B |